Earnings Labs
Liminatus Pharma, Inc. Class A Common Stock logo

Liminatus Pharma, Inc. Class A Common Stock (LIMN)

NASDAQ·Healthcare·Biotechnology

$0.20

-1.78%

Mkt Cap $6.34M

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 31, 2026

————-$0.03———
Q4 2025

Nov 13, 2025

————-$0.07———
Q4 2025

Oct 3, 2025

————-$0.05———